Good evening :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Wanbury Ltd

WANBURY

Wanbury Ltd

WANBURY
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,004 cr, stock is ranked 1,493
High RiskStock is 3.51x as volatile as Nifty
305.755.00% (-16.10)
305.755.00% (-16.10)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,004 cr, stock is ranked 1,493
High RiskStock is 3.51x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,004 cr, stock is ranked 1,493
High RiskStock is 3.51x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
18.9635.94—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.536.560.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Wanbury Limited is a pharmaceutical company which offers active pharmaceutical ingredient in over 70 countries.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 8.56%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.18% to 0.16%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue424.66523.49447.80400.70451.23394.92589.07500.56604.20606.95
Raw Materialssubtract182.15191.12166.40201.26169.75228.53325.07274.31306.52506.90
Power & Fuel Costsubtract18.5118.7415.2614.4615.3817.1318.4120.5924.58
Employee Costsubtract85.5987.7787.3275.8967.4864.1574.8181.0086.92
Selling & Administrative Expensessubtract70.4376.6264.4563.7055.3645.4955.1359.2876.53
Operating & Other expensessubtract34.2241.03105.5920.5236.0419.202.4441.8911.10
Depreciation/Amortizationsubtract9.0510.3210.309.979.689.7511.4512.3813.0313.21
Interest & Other Itemssubtract31.8735.5130.8639.8832.8723.0720.6121.3929.1833.46
Taxes & Other Itemssubtract0.000.39-0.38-0.140.210.20-0.350.110.380.40
EPS-3.5928.71-13.63-10.4726.46-5.0428.26-3.1817.1016.18
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2014

Annual report

PDF
FY 2015

Annual Report Unavailable

FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Wanbury Ltd17.9535.94—
Sun Pharmaceutical Industries Ltd45.356.470.75%
Cipla Ltd28.514.380.89%
Torrent Pharmaceuticals Ltd68.4516.540.84%

Price Comparison

Compare WANBURY with any stock or ETF
Compare WANBURY with any stock or ETF
WANBURY
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding

Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.22%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding39.77%0.00%0.00%1.02%59.20%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.18%0.22%1.02%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

WANBURY has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 29, 2010

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 29, 2010

News & Opinions
Corporate
Wanbury announces board meeting date

Wanbury will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Wanbury to conduct AGM

Wanbury announced that the 36th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Wanbury consolidated net profit declines 77.83% in the June 2024 quarter

Net profit of Wanbury declined 77.83% to Rs 1.04 crore in the quarter ended June 2024 as against Rs 4.69 crore during the previous quarter ended June 2023. Sales declined 10.38% to Rs 131.11 crore in the quarter ended June 2024 as against Rs 146.29 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales131.11146.29 -10 OPM %8.379.12 - PBDT4.338.18 -47 PBT1.044.99 -79 NP1.044.69 -78 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Wanbury to hold board meeting

Wanbury will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Wanbury surges 5% after USFDA issues Zero observations for Patalganga site

5 months agoBusiness Standard

Wanbury Consolidated June 2023 Net Sales at Rs 146.29 crore, up 25.09% Y-o-Y

1 year agoMoneycontrol

Stocks In Focus: Adani, Indian Hotels, Lupin, Kalpataru, in news Today

1 year agoThe Hindu Businessline

Wanbury Consolidated September 2022 Net Sales at Rs 123.96 crore, down 0.11% Y-o-Y

2 years agoMoneycontrol

Wanbury Standalone September 2022 Net Sales at Rs 123.96 crore, down 0.11% Y-o-Y

2 years agoMoneycontrol

Wanbury reports consolidated net profit of Rs 82.54 crore in the March 2022 quarter

2 years agoBusiness Standard